Göran Gannedahl
Director/Board Member at ECTIN RESEARCH AB
Profile
Göran Gannedahl is currently the Director at Ectin Research AB since 2022.
Previously, he worked as the VP-Medical, Regulatory Affairs & Research at Pronova BioPharma ASA from 2008 to 2012.
He holds a doctorate degree from Karolinska Institutet and the University of Uppsala.
Göran Gannedahl active positions
| Companies | Position | Start |
|---|---|---|
| ECTIN RESEARCH AB | Director/Board Member | 01/05/2022 |
Former positions of Göran Gannedahl
| Companies | Position | End |
|---|---|---|
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Chief Tech/Sci/R&D Officer | - |
Training of Göran Gannedahl
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ECTIN RESEARCH AB | Health Technology |
| Private companies | 1 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
- Stock Market
- Insiders
- Göran Gannedahl